Petros Pharmaceuticals Stock Market Value
| PTPI Stock | USD 0.26 0.01 4.00% |
| Symbol | Petros |
Petros Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Petros Pharmaceuticals. If investors know Petros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Petros Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.80) | Revenue Per Share 0.99 | Quarterly Revenue Growth (0.29) | Return On Assets (0.31) | Return On Equity (0.64) |
The market value of Petros Pharmaceuticals is measured differently than its book value, which is the value of Petros that is recorded on the company's balance sheet. Investors also form their own opinion of Petros Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Petros Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Petros Pharmaceuticals' market value can be influenced by many factors that don't directly affect Petros Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Petros Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Petros Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Petros Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Petros Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Petros Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Petros Pharmaceuticals.
| 11/28/2023 |
| 11/22/2024 |
If you would invest 0.00 in Petros Pharmaceuticals on November 28, 2023 and sell it all today you would earn a total of 0.00 from holding Petros Pharmaceuticals or generate 0.0% return on investment in Petros Pharmaceuticals over 360 days. Petros Pharmaceuticals is related to or competes with Sunshine Biopharma, Sonoma Pharmaceuticals, Alpha Teknova, Evoke Pharma, Cumberland Pharmaceuticals, Painreform, and Lifecore Biomedical. Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on mens health therapeutics More
Petros Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Petros Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Petros Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 45.54 | |||
| Value At Risk | (7.89) | |||
| Potential Upside | 6.25 |
Petros Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Petros Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Petros Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Petros Pharmaceuticals historical prices to predict the future Petros Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (1.08) | |||
| Treynor Ratio | 0.4537 |
Petros Pharmaceuticals Backtested Returns
Petros Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.0617, which implies the firm had a -0.0617% return per unit of risk over the last 3 months. Petros Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Petros Pharmaceuticals' Coefficient Of Variation of (2,169), risk adjusted performance of (0.03), and Variance of 36.9 to confirm the risk estimate we provide. The company holds a Beta of -0.64, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Petros Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Petros Pharmaceuticals is likely to outperform the market. At this point, Petros Pharmaceuticals has a negative expected return of -0.38%. Please make sure to check Petros Pharmaceuticals' value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if Petros Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.40 |
Average predictability
Petros Pharmaceuticals has average predictability. Overlapping area represents the amount of predictability between Petros Pharmaceuticals time series from 28th of November 2023 to 26th of May 2024 and 26th of May 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Petros Pharmaceuticals price movement. The serial correlation of 0.4 indicates that just about 40.0% of current Petros Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.4 | |
| Spearman Rank Test | 0.28 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Petros Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Petros Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Petros Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Petros Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Petros Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Petros Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Petros Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Petros Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Petros Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Petros Pharmaceuticals Lagged Returns
When evaluating Petros Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Petros Pharmaceuticals stock have on its future price. Petros Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Petros Pharmaceuticals autocorrelation shows the relationship between Petros Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Petros Pharmaceuticals.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Petros Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Petros Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Petros Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Petros Pharmaceuticals Stock:Check out Petros Pharmaceuticals Correlation, Petros Pharmaceuticals Volatility and Petros Pharmaceuticals Alpha and Beta module to complement your research on Petros Pharmaceuticals. For more detail on how to invest in Petros Stock please use our How to Invest in Petros Pharmaceuticals guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Petros Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.